Background and objective: Inflammatory bowel disease (IBD), including Crohn's disease
and ulcerative colitis, is a chronic inflammatory disorder characterized by aberrant immune …

Inflammatory bowel disease (IBD) is a multifactorial chronic disease, commonly associated
with alteration in the composition and function of gut microbiota. This process can lead to a …

This review describes current evidence supporting butyrate impact in the homeostatic
regulation of the digestive ecosystem in health and inflammatory bowel diseases (IBDs) …

Butyrate is a key energy source for colonocytes and is produced by the gut microbiota
through fermentation of dietary fiber. Butyrate is a histone deacetylase inhibitor and also …

The gastrointestinal (GI) system contains many different types of immune cells, making it a
key immune organ system in the human body. In the last decade, our knowledge has …

Inflammatory bowel disease (IBD) refers to a group of heterogeneous disorders associated
with chronic inflammation of the gut, having a high rate of incidence in the world. In the …

Butyrate is a four-carbon short-chain fatty acid that improves colonic trophism. Although
several studies have shown the benefits of butyrate enemas in ulcerative colitis (UC) …

Background Butyrate-producing gut bacteria are reduced in patients with active
inflammatory bowel disease (IBD), supporting the hypothesis that butyrate supplementation …

Butyrate is produced by microbial fermentation in the large intestine of humans and animals.
It serves as not only a primary nutrient that provides energy to colonocytes, but also a …

Background Butyrate, a short‐chain fatty acid, is a main end‐product of intestinal microbial
fermentation of mainly dietary fibre. Butyrate is an important energy source for intestinal …